Ge Li
Founder, Chairman & CEO
WuXi AppTec Co., Ltd.
Dr.Ge Li is the Founder,Chairman and Chief Executive Officer of WuXi AppTec, a leading R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries with 11,000 employees and 24 R&D sites and offices worldwide.

An entrepreneur,a leader, and a scientist at heart, Dr. Li, named as one of "The 25 Most Influential People in Biopharma in 2015" by FierceBiotech, is working to lead the transformation of biopharma R&D with the conviction that more efficient and cost-effective R&D should be at the core of better medicines for patients.

A pioneer in biopharma R&D service industry in China, Dr. Li founded WuXi in December 2000 with four employees, China's first modern chemistry hood, and a single 7,000-square-foot chemistry laboratory. During the past 15 years as its Chairman and CEO, Dr. Li has led WuXi's rapid growth into a global R&D enabling powerhouse with a pioneering open-access platform as the cornerstone. Today, WuXi's platform is enabling thousands of biopharma and medical device R&D programs from over 2000 collaborators worldwide,and has contributed to many partners' successes:clinical milestones, successful IPOs, breakthrough designations, and blockbuster drugs that are profoundly improving patients' lives.

Dr. Li's visionary leadership and achievements have won him numerous prestigious awards and honors, including the "2016 OBA Brilliant Achievement Award", "2015 SCRIP Executive of the Year Award", "The 25 Most Influential People in Biopharma in 2015","Forbes 25 Notable Chinese-Americans", "The 60 Most Influential People during 60 Years Pharmaceutical Development in China",and "Ernst & Young Entrepreneur of the Year China Award". WuXi has also received many distinguished recognition, including the "Asian CRO Company of the Year" Award (2015) ,the "North American Open-Access R&D Technology Leadership• Award (2015), "Best Company in an Emerging Market" (2014), "Deloitte Technology Fast 500 Asia Pacific" (2004-2009, 6 consecutive years), and "Fast Company 50 Most Innovative Companies" (2009).

Dr. Li earned his bachelor's degree in Chemistry in 1989 from Peking University and his doctoral degree in Organic Chemistry from Columbia University in 1993. Prior to WuXi, Dr.Li was a founding scientist at Pharmacopeia Inc.,a leading combinatorial chemistry platform company.

Dr. Li is a co-author and co-inventor to over 100 scientific publications and issued or pending patents.